Anavex Life Sciences Corp (AVXL)

[seventhwave]

Yes, blu_1, the drug works remarkably well on at least some and maybe more and a foolproof design for the next trial will seal the deal. I think the 1.5yr data release likely has surprise/s in store rather than being more of the same.

I am confident that 2 to 3 years from P1/2 trial extensions will practically guarantee approval at the first 6-month interim look IF stat sig. This statinesque/beta-blocker-like (or even better) safety profile ensures that once approved the drug will rule the roost for long with immense detracting power against subsequent competition. It will stick like superglue.

Oh, about all the talk on CEO comp... IMO, with the prize getting bigger and bigger every day in the eyes of the BOD, they are scrambling to ensure CEO comp is gravy enough so he's in for the long haul and doesn't sell out to the highest bidder. Besides, the options are struck at the money and those who are quoting $8mil don;t understand stock options.

NB: I just hope Rett doesn't play spoilsport as A2-73 really has been all about AZ so far.